Placebo Group:Oral Administration of Placebo

4 trials

Sponsors

Maoming People's Hospital, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, The First Affiliated Hospital of Nanchang University

Conditions

Metabolic-related (nonalcoholic) fatty liver diseaseNovel Coronavirus Pneumonia (COVID-19)Psoriasis

Phase 1

Phase I clinical study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamic characteristics of WD-890 tablets in Chinese healthy subjects

Active, not recruitingChiCTR2500100460

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyPsoriasis

Start: 2023-11-25Updated: 2025-04-14

Phase 4

Exocarpium Citri Grandis Relieves Symptoms of Novel Coronavirus Pneunomia (COVID-19): a Randomized Controlled Clinical Trial

RecruitingITMCTR2000003112

Maoming People's HospitalNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-01Updated: 2023-02-20

Exocarpium Citri Grandis Relieves Symptoms of Novel Coronavirus Pneunomia (COVID-19): a Randomized Controlled Clinical Trial

RecruitingChiCTR2000030804

Maoming People's HospitalNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-01Updated: 2020-03-16

Unknown Phase

Clinical Randomized Controlled Trial of Probiotics in the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

Active, not recruitingChiCTR2600124451

The First Affiliated Hospital of Nanchang UniversityMetabolic-related (nonalcoholic) fatty liver disease

Start: 2026-05-12Updated: 2026-05-18